Market Overview:
The global drug discovery outsourcing market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for drugs and rising expenditure on healthcare globally. Additionally, the growing focus on novel drug discovery and development is also contributing to the growth of this market. The small molecules segment is expected to dominate the global drug discovery outsourcing market during the forecast period, owing to their low cost and shorter timelines for development as compared to biologics. The hospitals and clinics segment is expected to be the largest application segment in this market during the forecast period, owingtothe increasing demand for drugs for treating various diseases.
Product Definition:
Drug discovery outsourcing is the process of contracting out the development of a new drug to another company or organization. The importance of drug discovery outsourcing lies in the fact that it can speed up the process of getting new drugs to market by leveraging the resources and expertise of other companies.
Small Molecules:
Small molecules are the chemical compounds that have a molecular weight less than 1000. They can be naturally occurring or synthetic (man-made). Small molecules can also refer to any drug or medication, for instance, insulin is a small molecule.
The global small molecule discovery and development market was valued at over USD 39 billion in 2015 and is expected to grow at an estimated CAGR of XX% during the forecast period.
Biologics:
Biologics is a class of drugs that are derived from living organisms and used to treat diseases. Biologics accounts for the largest share in drug discovery outsourcing market owing to its advantages such as specificity & sensitivity, cost-effectiveness, easy availability of raw materials and greater safety.
Advantages associated with biologics include high therapeutic value & efficacy along with lesser side effects which makes it an attractive option over traditional drugs.
Application Insights:
The market is segmented into hospitals and clinics, pharmaceutical companies, biotechnology companies, other research organizations and institutions. The hospitals and clinics segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as rising prevalence of chronic diseases that require longterm medication along with an increasing number of patients visiting hospitals & clinics for drug discovery & development services.
Pharmaceutical companies are expected to witness lucrative growth over the forecast period owing to factors such as growing demand for new drugs by consumers around the globe coupled with a rise in R&D expenditure by various pharmaceutical manufacturers. For instance, according to data published by IMS Health Canada Ltd., total R&D expenditure was valued at USD 305 billion globally in 2016 while it was valued at USD 281 billion globally in 2010 which represents a growth rate of 5%. Similarly Pfizer Inc.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of small molecule entities and biologics drug candidates in the U.S., along with an increase in R&D spending, is expected to drive this regional market over the forecast period. Europe followed North America in terms of revenue share and accounted for 26% of the total market share owing to an increase in outsourcing activities by leading companies operating within this region coupled with growing R&D initiatives undertaken by them. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as increasing healthcare expenditure levels, rising awareness about new therapies, improving healthcare infrastructure facilities within this region and rise adoption rates for novel therapeutics among patients across countries such as China & India & Australia etc.).
The key players operating within Asia Pacific are Outsourcing Pharmaceuticals (OSPHC), Sosei Heptares Inc.
Growth Factors:
- Increasing demand for novel drugs and therapies: The global market for novel drugs is expected to grow at a CAGR of 9.8% from 2016 to 2021. This is primarily due to the increasing incidence of chronic diseases, such as cancer, diabetes, and heart disease. The need for new and innovative drugs is also driven by the ever-growing population of aging adults who are susceptible to various age-related diseases.
- Rising R&D costs: The high cost of drug discovery and development has led pharmaceutical companies to outsource these activities to contract research organizations (CROs). Outsourcing allows companies to focus on their core competencies while reducing their R&D costs. In addition, CROs have the expertise and infrastructure needed to carry out complex drug discovery projects quickly and efficiently.
- Growing number of collaborations between CROs and pharma companies: A major trend in the outsourcing market is the growing number of collaborations between CROs and pharmaceutical companies. These partnerships allow both parties access to each other’s strengths – CROs can offer their expertise in drug discovery while pharma companies can provide fundingand marketing support for new products..
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Discovery Outsourcing Market Research Report
By Type
Small Molecules, Biologics
By Application
Hospitals and Clinics, Pharmaceutical Companies, Others
By Companies
Charles River Laboratories, Thermo Fisher Scientific, DomaineX, Evotec A.G., GenScript, Abbott Laboratories, GVkBiosciences, Agilent Technologies, Shimadzu, Bio-Rad, PerkinElmer, AMRI Global, LabCorp, WuXi AppTec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Drug Discovery Outsourcing Market Report Segments:
The global Drug Discovery Outsourcing market is segmented on the basis of:
Types
Small Molecules, Biologics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Pharmaceutical Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Charles River Laboratories
- Thermo Fisher Scientific
- DomaineX
- Evotec A.G.
- GenScript
- Abbott Laboratories
- GVkBiosciences
- Agilent Technologies
- Shimadzu
- Bio-Rad
- PerkinElmer
- AMRI Global
- LabCorp
- WuXi AppTec
Highlights of The Drug Discovery Outsourcing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small Molecules
- Biologics
- By Application:
- Hospitals and Clinics
- Pharmaceutical Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Discovery Outsourcing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug discovery outsourcing is the process of contracting with a third-party company to conduct preclinical and clinical trials for new drug candidates. Outsourcing can save companies time and money, as well as improve the speed and quality of drug development.
Some of the major players in the drug discovery outsourcing market are Charles River Laboratories, Thermo Fisher Scientific, DomaineX, Evotec A.G., GenScript, Abbott Laboratories, GVkBiosciences, Agilent Technologies, Shimadzu, Bio-Rad, PerkinElmer, AMRI Global, LabCorp, WuXi AppTec.
The drug discovery outsourcing market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug Discovery Outsourcing Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Drug Discovery Outsourcing Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Drug Discovery Outsourcing Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Drug Discovery Outsourcing Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Drug Discovery Outsourcing Market Size & Forecast, 2018-2028 4.5.1 Drug Discovery Outsourcing Market Size and Y-o-Y Growth 4.5.2 Drug Discovery Outsourcing Market Absolute $ Opportunity
Chapter 5 Global Drug Discovery Outsourcing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Drug Discovery Outsourcing Market Size Forecast by Type
5.2.1 Small Molecules
5.2.2 Biologics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Drug Discovery Outsourcing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Drug Discovery Outsourcing Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Pharmaceutical Companies
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug Discovery Outsourcing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug Discovery Outsourcing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Drug Discovery Outsourcing Analysis and Forecast
9.1 Introduction
9.2 North America Drug Discovery Outsourcing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Drug Discovery Outsourcing Market Size Forecast by Type
9.6.1 Small Molecules
9.6.2 Biologics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Drug Discovery Outsourcing Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Pharmaceutical Companies
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Drug Discovery Outsourcing Analysis and Forecast
10.1 Introduction
10.2 Europe Drug Discovery Outsourcing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Drug Discovery Outsourcing Market Size Forecast by Type
10.6.1 Small Molecules
10.6.2 Biologics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Drug Discovery Outsourcing Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Pharmaceutical Companies
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Drug Discovery Outsourcing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Drug Discovery Outsourcing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Drug Discovery Outsourcing Market Size Forecast by Type
11.6.1 Small Molecules
11.6.2 Biologics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Drug Discovery Outsourcing Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Pharmaceutical Companies
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Drug Discovery Outsourcing Analysis and Forecast
12.1 Introduction
12.2 Latin America Drug Discovery Outsourcing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Drug Discovery Outsourcing Market Size Forecast by Type
12.6.1 Small Molecules
12.6.2 Biologics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Drug Discovery Outsourcing Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Pharmaceutical Companies
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Drug Discovery Outsourcing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Drug Discovery Outsourcing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Drug Discovery Outsourcing Market Size Forecast by Type
13.6.1 Small Molecules
13.6.2 Biologics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Drug Discovery Outsourcing Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Pharmaceutical Companies
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug Discovery Outsourcing Market: Competitive Dashboard
14.2 Global Drug Discovery Outsourcing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Charles River Laboratories
14.3.2 Thermo Fisher Scientific
14.3.3 DomaineX
14.3.4 Evotec A.G.
14.3.5 GenScript
14.3.6 Abbott Laboratories
14.3.7 GVkBiosciences
14.3.8 Agilent Technologies
14.3.9 Shimadzu
14.3.10 Bio-Rad
14.3.11 PerkinElmer
14.3.12 AMRI Global
14.3.13 LabCorp
14.3.14 WuXi AppTec